Old TB vaccine tapped in global race to shield frontline workers from coronavirus
NCT ID NCT04362124
Summary
This study aimed to see if giving healthcare workers the BCG vaccine, which is normally used to prevent tuberculosis, could help their immune systems fight off COVID-19 more effectively and prevent severe illness. The plan was to give 1,000 healthy doctors and nurses in Colombia either the BCG shot or a placebo and follow them for a year. However, the trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Program for Research and Control in Tropical Diseases - PECET
Medellín, Antioquia, 0004, Colombia
Conditions
Explore the condition pages connected to this study.